Report Detail
Global (United States, European Union and China) Alzheimer's Disease Patients Market Research Report 2019-2025
- RnM3640644 |
- 02 August, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
Alzheimer’s is a complex disease，though many marketed drugs have been approved for Alzheimer’s disease, but it still remains a significant area of unmet medical need. Currently there’s no cure for Alzheimer’s and its still waiting for its key product, numerous companies are developing novel treatments.
As the risk of getting the disease increases with age, the number of patients with the illness to be found in community will depend on the proportion of older people in the group.
Traditionally, the developed countries have large proportions of elderly people, and so they have many cases of Alzheimer’s disease in the community at one time.
At the mean time, developing countries are also undergoing a demographic transition so that more and more persons are surviving to an old age.
In 2019, the market size of Alzheimer's Disease Patients is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Alzheimer's Disease Patients.
This report studies the global market size of Alzheimer's Disease Patients, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Alzheimer's Disease Patients sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Forest Laboratorie
Eisai
H. Lundbeck A/S
Novartis
Merz GmbH & Co. KGaA
Johnson & Johnson
UCB
...
Market Segment by Product Type
Exelon
Aricept
Namenda
Razadyne
Axura
Ebixa
Nootropil
Prometax
Memac
Eranz
Market Segment by Application
Hospital
Drug Store
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Alzheimer's Disease Patients status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Alzheimer's Disease Patients manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Alzheimer's Disease Patients are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Alzheimer's Disease Patients Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Exelon
- 1.3.3 Aricept
- 1.3.4 Namenda
- 1.3.5 Razadyne
- 1.3.6 Axura
- 1.3.7 Ebixa
- 1.3.8 Nootropil
- 1.3.9 Prometax
- 1.3.10 Memac
- 1.3.11 Eranz
- 1.4 Market Segment by Application
- 1.4.1 Global Alzheimer's Disease Patients Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 Drug Store
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Alzheimer's Disease Patients Market Size
- 2.1.1 Global Alzheimer's Disease Patients Revenue 2014-2025
- 2.1.2 Global Alzheimer's Disease Patients Sales 2014-2025
- 2.2 Alzheimer's Disease Patients Growth Rate by Regions
- 2.2.1 Global Alzheimer's Disease Patients Sales by Regions 2014-2019
- 2.2.2 Global Alzheimer's Disease Patients Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Alzheimer's Disease Patients Sales by Manufacturers
- 3.1.1 Alzheimer's Disease Patients Sales by Manufacturers 2014-2019
- 3.1.2 Alzheimer's Disease Patients Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Alzheimer's Disease Patients Revenue by Manufacturers (2014-2019)
- 3.2.2 Alzheimer's Disease Patients Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Alzheimer's Disease Patients Market Concentration Ratio (CR5 and HHI)
- 3.3 Alzheimer's Disease Patients Price by Manufacturers
- 3.4 Key Manufacturers Alzheimer's Disease Patients Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Alzheimer's Disease Patients Market
- 3.6 Key Manufacturers Alzheimer's Disease Patients Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Exelon Sales and Revenue (2014-2019)
- 4.1.2 Aricept Sales and Revenue (2014-2019)
- 4.1.3 Namenda Sales and Revenue (2014-2019)
- 4.1.4 Razadyne Sales and Revenue (2014-2019)
- 4.1.5 Axura Sales and Revenue (2014-2019)
- 4.1.6 Ebixa Sales and Revenue (2014-2019)
- 4.1.7 Nootropil Sales and Revenue (2014-2019)
- 4.1.8 Prometax Sales and Revenue (2014-2019)
- 4.1.9 Memac Sales and Revenue (2014-2019)
- 4.1.10 Eranz Sales and Revenue (2014-2019)
- 4.2 Global Alzheimer's Disease Patients Sales Market Share by Type
- 4.3 Global Alzheimer's Disease Patients Revenue Market Share by Type
- 4.4 Alzheimer's Disease Patients Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Alzheimer's Disease Patients Sales by Application
6 United States
- 6.1 United States Alzheimer's Disease Patients Breakdown Data by Company
- 6.2 United States Alzheimer's Disease Patients Breakdown Data by Type
- 6.3 United States Alzheimer's Disease Patients Breakdown Data by Application
7 European Union
- 7.1 European Union Alzheimer's Disease Patients Breakdown Data by Company
- 7.2 European Union Alzheimer's Disease Patients Breakdown Data by Type
- 7.3 European Union Alzheimer's Disease Patients Breakdown Data by Application
8 China
- 8.1 China Alzheimer's Disease Patients Breakdown Data by Company
- 8.2 China Alzheimer's Disease Patients Breakdown Data by Type
- 8.3 China Alzheimer's Disease Patients Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Alzheimer's Disease Patients Breakdown Data by Company
- 9.2 Rest of World Alzheimer's Disease Patients Breakdown Data by Type
- 9.3 Rest of World Alzheimer's Disease Patients Breakdown Data by Application
- 9.4 Rest of World Alzheimer's Disease Patients Breakdown Data by Countries
- 9.4.1 Rest of World Alzheimer's Disease Patients Sales by Countries
- 9.4.2 Rest of World Alzheimer's Disease Patients Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Forest Laboratorie
- 10.1.1 Forest Laboratorie Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Alzheimer's Disease Patients
- 10.1.4 Alzheimer's Disease Patients Product Introduction
- 10.1.5 Forest Laboratorie Recent Development
- 10.2 Eisai
- 10.2.1 Eisai Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Alzheimer's Disease Patients
- 10.2.4 Alzheimer's Disease Patients Product Introduction
- 10.2.5 Eisai Recent Development
- 10.3 H. Lundbeck A/S
- 10.3.1 H. Lundbeck A/S Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Alzheimer's Disease Patients
- 10.3.4 Alzheimer's Disease Patients Product Introduction
- 10.3.5 H. Lundbeck A/S Recent Development
- 10.4 Novartis
- 10.4.1 Novartis Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Alzheimer's Disease Patients
- 10.4.4 Alzheimer's Disease Patients Product Introduction
- 10.4.5 Novartis Recent Development
- 10.5 Merz GmbH & Co. KGaA
- 10.5.1 Merz GmbH & Co. KGaA Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Alzheimer's Disease Patients
- 10.5.4 Alzheimer's Disease Patients Product Introduction
- 10.5.5 Merz GmbH & Co. KGaA Recent Development
- 10.6 Johnson & Johnson
- 10.6.1 Johnson & Johnson Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Alzheimer's Disease Patients
- 10.6.4 Alzheimer's Disease Patients Product Introduction
- 10.6.5 Johnson & Johnson Recent Development
- 10.7 UCB
- 10.7.1 UCB Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Alzheimer's Disease Patients
- 10.7.4 Alzheimer's Disease Patients Product Introduction
- 10.7.5 UCB Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Alzheimer's Disease Patients Sales Channels
- 11.2.2 Alzheimer's Disease Patients Distributors
- 11.3 Alzheimer's Disease Patients Customers
12 Market Forecast
- 12.1 Global Alzheimer's Disease Patients Sales and Revenue Forecast 2019-2025
- 12.2 Global Alzheimer's Disease Patients Sales Forecast by Type
- 12.3 Global Alzheimer's Disease Patients Sales Forecast by Application
- 12.4 Alzheimer's Disease Patients Forecast by Regions
- 12.4.1 Global Alzheimer's Disease Patients Sales Forecast by Regions 2019-2025
- 12.4.2 Global Alzheimer's Disease Patients Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Alzheimer's Disease Patients. Industry analysis & Market Report on Alzheimer's Disease Patients is a syndicated market report, published as Global (United States, European Union and China) Alzheimer's Disease Patients Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Alzheimer's Disease Patients market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
